| Mar 18, 10 | Glaxo shines on Advair news but FTSE edges lower | | No data |
| Mar 11, 10 | Smith & Nephew stumbles on US patent reverse as FTSE falls back | | No data |
| Mar 11, 10 | AstraZeneca advances into emerging markets with Torrent deal | | No data |
| Mar 8, 10 | FTSE edges higher but AstraZeneca slips on drug disappointment | | No data |
| Mar 8, 10 | AstraZeneca under pressure after drug disappointment | | No data |
| Mar 3, 10 | AstraZeneca to close UK research centre with 1,200 job losses | | No data |
| Feb 23, 10 | Wolseley outperforms FTSE 100 on surprise profit news | | No data |
| Feb 23, 10 | AstraZeneca agrees to pay £505m to settle UK tax dispute | | No data |
| Feb 23, 10 | AstraZeneca helps lift FTSE after earnings boost from £505m tax settlement | | No data |
| Feb 10, 10 | The Business: Jacob Wallenberg | | No data |
| Feb 3, 10 | BAE Systems drops after Goldman sell, as FTSE breaks winning run | | No data |
| Feb 3, 10 | AstraZeneca slides as FTSE makes an uncertain start | | No data |
| Jan 31, 10 | Job losses expected at GlaxoSmithKline | | No data |
| Jan 29, 10 | Banks and miners lift FTSE but AstraZeneca falls again | | No data |
| Jan 28, 10 | FTSE 100 ends day in negative territory after S&P report on UK banks | | No data |
| Jan 28, 10 | More job losses amid fears recession will blight Britain for years to come | | No data |
| Jan 24, 10 | UK firms face takeover onslaught as buyers take advantage of weak sterling | | No data |
| Jan 21, 10 | AstraZeneca advances on broker talk of R&D savings | | No data |
| Jan 21, 10 | Tullow gushes higher after Ghana oil find, but FTSE 100 slips back | | No data |
| Jan 20, 10 | Shire shines as pharmaceuticals get a boost from US senate win | | No data |
| Jan 19, 10 | FTSE buoyed by Wall Street but Barclays down on capital concerns | | No data |
| Jan 13, 10 | Shell slides on profit fears as FTSE falls for the second day | | No data |
| Jan 7, 10 | RBS slips despite disposal talk but Lloyds is lifted by analysts | | No data |
| Jan 7, 10 | AstraZeneca advances after settling Nexium patent dispute | | No data |